Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.4K Hold
211
0.04% 122
2026
Q1
$74.2K Hold
211
0.05% 118
2025
Q4
$69.1K Hold
211
0.04% 120
2025
Q3
$59.5K Sell
211
-65
-24% -$18.9K 0.03% 126
2025
Q2
$77.1K Hold
276
0.05% 118
2025
Q1
$86K Hold
276
0.06% 111
2024
Q4
$71.9K Buy
276
+150
+119% +$44.5K 0.04% 118
2024
Q3
$40.6K Hold
126
0.03% 125
2024
Q2
$39.4K Hold
126
0.03% 128
2024
Q1
$35.8K Hold
126
0.02% 134
2023
Q4
$36.3K Hold
126
0.03% 95
2023
Q3
$33.9K Hold
126
0.03% 100
2023
Q2
$28K Hold
126
0.02% 103
2023
Q1
$31.9K Buy
+126
New +$30.9K 0.03% 103

Other funds holding AMGN

General Partner Inc's AMGN Position: Q2 2026 in Review

General Partner Inc held its Amgen (AMGN) position steady in Q2 2026 at 211 shares worth $76.4K. The position accounts for 0.04% of the portfolio, ranked #122.

General Partner Inc first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $86K in Q1 2025. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • General Partner Inc held 211 shares of Amgen worth $76.4K as of Q2 2026.
  • General Partner Inc left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.04% of General Partner Inc's portfolio in Q2 2026, its #122 holding.
  • General Partner Inc first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • General Partner Inc's Amgen position peaked at $86K in Q1 2025.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on General Partner Inc's 13F filing for Q2 2026, filed 6 Jul 2026.